LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 75 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $212,000 | -64.4% | 53,943 | -20.3% | 0.01% | -57.1% |
| Q3 2019 | $596,000 | +40.6% | 67,682 | +47.8% | 0.01% | +55.6% |
| Q2 2019 | $424,000 | +196.5% | 45,802 | +201.9% | 0.01% | +125.0% |
| Q4 2018 | $143,000 | -77.9% | 15,173 | -62.4% | 0.00% | -81.0% |
| Q2 2016 | $646,000 | -56.8% | 40,385 | -43.6% | 0.02% | -51.2% |
| Q1 2016 | $1,496,000 | – | 71,547 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |